rated by SDS-PAGE, transferred to PVDF membranes, and probed by FFGV , IPEN and TEGE neoepitope antibodies, and by antibodies against aggrecan G1 and G3 domains. Immunodetected aggrecan fragments were quantified using chemiluminescence and digital luminescence imager. Nand C-terminal ends not verified by immunodetection where estimated using a calculation model. Results: The Western blot results showed that MMP-3 cleaves aggrecan in several sites in six separate regions (a-f, Fig. 1 ). Time dependent kinetic studies showed that the most preferred MMP cuts in aggrecan were in region a, e and f. The second most preferred cut occurred in region d, while cuts in region b and c were the least preferred. Also, in both young (knee healthy) and adult (OA) cartilage, Western blot quantification of the in vivo MMP-generated G1-IPEN fragment was 3 times lower (mol/mol) compared to the in vivo aggrecanase generated G1-TEGE fragment. Except for the common G1-IPEN other fragments were detected in cartilage in vivo (G1-CS1, 210-245 kDa) and in OA synovial fluid (ARGS-CS1, 130-160 kDa; CS1-KEEE 125 kDa) with suggested N-and C-terminals from MMP cuts in the CS1 region. Figure 1. Several MMP cleavage sites were found in six regions (a-f) in human aggrecan. OA cartilage (A1D1) was in vitro digested by MMP-3 and fragments were visualized by Western blot. Illustration of human aggrecan, MMP cleavage sites and MMP-3 in vitro generated fragments (Mw in kDA).
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Conclusions:
There are at least 24 potentially MMP cleavage sites in the CS1 domain but our results suggest that only a few sites, in the beginning and in the end of this domain, are available for MMP proteolysis. Two of the MMP cuts, in the IGD and in the KS region, results in loss of most of the glycosaminoglycans from aggrecan and thereby loss of cartilage resilience. Quantification of in vivo generated G1-IPEN and G1-TEGE fragments indicate significant contribution of MMP proteolysis against aggrecan in both young (knee healthy) and adult (OA) cartilage.
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SERUM AND URINARY BIOCHEMICAL MARKERS FOR KNEE AND HIP OSTEOARTHRITIS: A SYSTEMATIC REVIEW APPLYING THE CONSENSUS BIPED CRITERIA
W.E. van Spil 1 , J. DeGroot 2 , W.F. Lems 3 , F.P. Lafeber 1 1 Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands; 2 Business Unit BioSci., TNO Quality of Life, Zeist, Netherlands; 3 Rheumatology, VU Univ. Med. Ctr., Amsterdam, Netherlands Purpose: Molecules that are released into biological fluids during matrix metabolism and/or cellular activity in articular cartilage, subchondral bone, and synovial tissue could serve as biochemical markers of the process of osteoarthritis (OA). Unfortunately, actual breakthroughs in the biochemical OA marker field are limited so far. Critical evaluation of knowledge on the performance of currently available biochemical OA markers could guide and stimulate further biochemical OA marker research. Therefore, biochemical OA marker performance was systematically reviewed according to the "BIPED" classification, as published in 2006 in O&C. Methods: PubMed, Scopus and EMBASE were systematically searched for publications on blood and urinary biochemical markers in human primary knee and hip OA. 84 relevant publications were identified. Data were scored and tabulated according to the "BIPED" classification. Results: 26 biochemical OA markers were scored according to the "BIPED" classification structure. Comparison of individual biochemical marker performance was hampered by an uneven distribution of "BIPED" scores; uCTX-II and sCOMP were investigated most extensively. Also, studies showed heterogenic designs. The majority of studies involved relatively small cohorts and/or a cross-sectional design. Therefore, comparison of categories of biochemical markers was performed instead. Biochemical markers of cartilage degradation were investigated most extensively and performed well in comparison with other categories. Biochemical markers of bone metabolism performed less adequately. Biochemical markers of synovial tissue activity were investigated minimally, but performed relatively well.
Conclusions: This systematic review shows that there is a lack of consistent, high-quality evidence for the vast majority of commercially available biochemical OA markers. This lack of interest for some of the markers is not necessarily supported by publications showing their limited applicability. Additional investigation of biochemical OA markers in large-scale and/or longitudinal cohort studies is crucial to increase our knowledge on the applicability of these markers. Importantly, also the nature, origin and metabolism of biochemical markers need further investigation. International standardization of such future investigations should be pursued to obtain more high-quality, homogenous data on the full spectrum of biochemical markers. Finally, all involved parties should realize that most biochemical markers are still in an explorative stage and publication bias is therefore undesirable and should be prevented. Purpose: To explore prognostication of incident radiographic osteoarthritis (OA) at the knee with OA-related biomarkers: cartilage oligomeric matrix protein (COMP), hyaluronan (HA), high-sensitivity C-reactive protein (hsCRP), and keratan sulfate (KS) in a large, community-based sample. Methods: Baseline serum biomarkers of COMP,and KS were measured using in-house sandwich enzyme linked immunosorbent assays, HA was measured with the Hylauronic Acid Test kit, and hsCRP was measured with the UBI Magiwel Enzyme Immunoassay for 803 participants recruited from 1991-1997 in the Johnston County Osteoarthritis Project. Follow-up assessments were completed from 1999-2003 (mean = 6.3 years; range= 3.0 -10.2 years). Linked baseline and follow-up anterior-posterior radiographs with weight-bearing and footmat positioning were read for Kellgren-Lawrence (KL) grade (0-4) and osteophyte (OST) and joint space narrowing (JSN; both 0-3 with Burnett atlas). Three incident radiographic OA outcomes were explored and defined as: 1) a KL grade of 0-1 at baseline and ≥2 at follow-up, 2) an OST grade=0 at baseline and ≥1 at follow-up, and 3) a JSN grade=0 at baseline and ≥1 at follow-up. Five hundred forty two knees were at risk for incident OA by KL grades (KL grade of 0-1 at baseline), 349 knees at risk for incident OST formation (OST=0 at baseline), and 440 knees at risk for incident JSN (JSN=0 at baseline). For each outcome, Cox regression models were used to estimate the hazard ratio (HR) for a 1-unit increase in the natural log of each biomarker, adjusting for age, race, gender, and body mass index and accounting for bilateral clustering of knees using robust variance estimates. History of lower extremity injury (knee or hip injury or fracture) and chronic knee symptoms were explored as potential modifiers of the association. Results: In adjusted models, the hazard of incident knee OA by KL and OST increased with higher baseline lnCOMP levels (adjusted HR [aHR] = 1.46, 95% confidence interval [CI] = 0.96-2.23, and aHR= 2.26, 95% CI =1.45-3.53, respectively). The hazard of incident knee JSN also increased with higher lnCOMP levels (aHR=2.14, 95% CI= 1.32-3.47) and higher lnHA levels (aHR=1.63, 95% CI= 1.26-2.12). In unstratified analyses, higher levels of lnhsCRP and lnKS did not predict the incident knee outcomes. Neither history of lower extremity injury nor chronic knee symptoms was a strong modifier of these associations (p > 0.10). However, a pattern was observed of higher adjusted HRs for lnCOMP, lnHA, and, most notably, for lnKS with OST and JSN outcomes among knees with chronic symptoms at baseline compared to knees without symptoms. Conclusions: Higher baseline lnCOMP and lnHA levels were associated with incident knee OA, OST, and JSN over an average follow-up period of 6.3 years. These results did not vary by history of lower extremity injury, but this interpretation is incomplete due to power limitations and the potential misclassification that comes with self-report and long duration since reported injury. The presence of chronic knee symptoms, in combination with higher levels of serum COMP, HA, or KS, may provide clues to the early detection of OA.
HYPOCHLOROUS ACID IN OSTEOARTHRITIC CARTILAGE AND SYNOVIAL FLUID -AN EX-VIVO HRMAS STUDY
K. Shet, J. Kurhanewicz, M. Ries, X. Li Univ. of California, San Franscisco, San Francisco, CA Purpose: Proteoglycan degradation and alteration in the cartilage has been considered an important marker for detecting and measuring the progress of OA. Hypoxic conditions, reactive oxygen species (ROS) and an elevation in the activities of proteolytic enzymes (aggrecanases) are considered as potential factors that cause this degradation. Recent evidence shows that myeloperoxidase mRNA increased in OA. Myeloperoxidase catalyses the formation of hypochlorous acid (HOCl). HOCL is a ROS and causes a breakdown of the glycosidic linkage in the cartilage polymers namely N-acetyl-glucosamine, thereby making the N-Ac groups more mobile and this results in an enhancement of the N-Ac resonance in OA cartilage. Acetate is a final by-product of the degradation of N-Acetyl side chains in the polysaccharides of cartilage brought about by HOCl. With increasing HOCl activity in OA there is an increase in the acetate resonance. The aim of this study was to analyse cartilage and synovial fluid samples from severe OA patients using high resolution magic angle spinning NMR spectroscopy at 11.7 T to detect the presence of hypochlorous activity in OA. Methods: Six OA cartilage samples and synovial fluid specimens were harvested from 6 patients who underwent Total Knee Arthroplasty (TKA) surgeries; Cartilage samples were acquired using 3.5 mm biopsy punches from the lateral inferior femoral condyle. The samples were flash frozen at -80°C for storage. The samples were scanned in a 500MHz Varian INOVA spectrometer in a 30μL zirconium rotor which was spun at a rate of 2.25 kHz. The reference used was 0.75 mass % 3-(trimethylsilyl) propionic-2, 2, 3, 3-d4 acid (TSP in D2O). The 1-D HR-MAS NMR spectra were acquired at a temperature of 1°C. 1-D Carr-Purcell-Meiboom-Gill (CPMG) sequence that was rotor synchronized (i.e., τ delay = n x (spin rate)-1, where n is an even number) with an echo-time of 44 ms for cartilage and 60 ms for synovial fluid was acquired for each sample. A spectral bandwidth of 20 kHz was used in the above experiment. The CPMG acquisition was preceded by a 2-sec water pre-saturation pulse to minimize the water signal at 5 ppm and to ensure a flat baseline. The NMR spectra were processed using the ACD Labs 1D NMR processor (ver. 8.0). The 1D FID's were apodized with an exponential function, Fourier transformed, phase-corrected, baseline corrected and referenced to TSP at 0 ppm. Results: Figure 1 (a) and (b) show the Carr-Purcell Meiboom Gill (CPMG) spectra of cartilage and synovial fluid drawn from a severe OA patient. The metabolites in the spectra that may relate to free radical effect on cartilage are the N-Acetyl (N-Ac) resonance and acetate (A). The N-Ac peak at 2.04 ppm is known to arise from the glycoproteins. Free radicals cause a breakdown of the glycosidic linkage, resulting in an enhancement of the N-Ac resonance in OA cartilage. Acetate is a final by-product of the degradation of N-Acetyl side chains. With increasing HOCl activity in OA there is an increase in the acetate resonance at 1.92 ppm. The N-Ac and acetate resonance are sharper in case of synovial fluid. Conclusions: An enhancement of the N-acetyl resonance in both the cartilage and synovial fluid spectra could be attributed to degradation in OA. This degradation may be due ROS activity. The detection of acetate in OA specimens in both cartilage and synovial fluid specimens is evidence of HOCL activity in OA. It is also important to note that the detection of acetate in synovial fluid indicates the fact that there is a movement of HOCL and products of HOCL degradation from cartilage to the synovial space. This information is vital in the design of anti-oxidant therapy to reduce ROS damage and to treat rheumatic disease. 
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